Company intelligence / Profile preview

Rubidoux Research

Boston, Massachusetts, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Rubidoux Research is a boutique consultancy founded in 2023 by David Thompson, PhD, specializing in health economics, outcomes research, and real-world evidence generation for the life sciences sector. The company supports clients with study design, data analytics, and operational definitions for RWE studies. It collaborates with industry partners on projects involving algorithm development for patient identification and outcome measurement using real-world data sources[1][2][5].

Therapeutic areas: Other
Modalities: Not applicable
Industry: Consulting

Partnerships

NavidenceUniversity of Utah School of MedicineUPMC-University of Pittsburgh

Beyond the preview

Go deeper on Rubidoux Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rubidoux Research.

Explore the full profile